Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
Waeckerle-Men Y, Uetz-von Allmen E, Fopp M, von Moos R, Böhme C, Schmid HP, Ackermann D, Cerny T, Ludewig B, Groettrup M, Gillessen S.
Waeckerle-Men Y, et al. Among authors: gillessen s.
Cancer Immunol Immunother. 2006 Dec;55(12):1524-33. doi: 10.1007/s00262-006-0157-3. Epub 2006 Apr 13.
Cancer Immunol Immunother. 2006.
PMID: 16612599
Free PMC article.
Clinical Trial.